Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles.
Purified muscarinic receptors (0.5-10 nmol of L-[3H]quinuclidinyl benzilate-binding sites/mg of protein) from bovine brain and the GTP-dependent regulatory protein, Go, were reconstituted with a lipid mixture of phosphatidylcholine and cholesterol. Essentially all of the receptors could interact with Go as evinced by increases in affinity for agonist as large as 800-fold. Both the alpha and beta gamma subunits of Go were required for this effect. Similarly, both subunits were required for the stimulation of guanine nucleotide exchange by agonists. This latter action of the receptor on Go was catalytic and potentiated markedly by prior treatment with dithiothreitol. Initially, agonist stimulation of association of GTP and guanosine 5'-(3-O-thio)triphosphate (GTP gamma S) to Go was small and variable due to high basal rates. Prior addition of excess GDP inhibited the basal rate of exchange but allowed stimulation by agonists. Under these conditions, oxotremorine stimulated the rates of association of GTP gamma S up to 10-fold. This selective effect was not mimicked by GTP which inhibited both the basal and hormone-dependent rates. Direct examination of the association of GTP and GDP to Go demonstrated that agonist caused either stimulation or marked inhibition, respectively. These results indicate that receptors stimulate guanine nucleotide exchange on G proteins by both increasing the rates of dissociation of nucleotides and altering their relative affinities such that binding of GTP becomes highly favored over GDP. This would ensure the activation of G proteins by receptors in the presence of both nucleotides.
Florio
V A
VA
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.
Sternweis
P C
PC
D000818:Animals; D001921:Brain / Q000502:physiology*; D002417:Cattle; D004229:Dithiothreitol / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000502:physiology*; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D006153:Guanosine Diphosphate / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D066298:In Vitro Techniques; D046911:Macromolecular Substances; D010095:Oxotremorine / Q000494:pharmacology; D010713:Phosphatidylcholines; D011976:Receptors, Muscarinic / Q000502:physiology*; D013329:Structure-Activity Relationship; D013873:Thionucleotides / Q000378:metabolism
D046911:Macromolecular Substances; D010713:Phosphatidylcholines; D011976:Receptors, Muscarinic; D013873:Thionucleotides; D006153:Guanosine Diphosphate; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D010095:Oxotremorine; D006160:Guanosine Triphosphate; D019204:GTP-Binding Proteins; D004229:Dithiothreitol